Developer docs
API playgroundTry for free, no card

Search company profiles

Lucas Research

Full company profile

uuid0007zus

Namestring
Lucas Research
Legal namestring
Lucas Research
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Lucas Research is a privately-held clinical research site network founded in 2004 by Dr. K. Jean Lucas, a board-certified endocrinologist with fellowship training at Duke University Medical Center and over 250 completed clinical research studies. The company specializes in endocrine and metabolic disease trials, actively recruiting for studies in non-alcoholic fatty liver disease, diabetes, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders. Operations are anchored by a headquarters in Morehead City, North Carolina, with two additional regional offices in New Bern and Hickory, NC. The firm employs between 11 and 50 staff and is founder-owned with no disclosed institutional investment.

The core technical asset is a Fibroscan device providing non-invasive ultrasound-based transient elastography liver assessments, offered free to patients as both a screening service and a recruitment funnel into trials. A standard Athena-based patient portal supports participant scheduling, communication, and record access. The product portfolio comprises clinical trial execution services (the core offering), Fibroscan diagnostic imaging (a recruitment and community-engagement anchor), and the patient portal. There is no proprietary AI/ML tooling, no API surface, and no mobile application; technology footprint is conventional for a community-based research site.

Lucas Research operates a professional services revenue model: pharmaceutical sponsors and Contract Research Organizations pay the site to execute clinical protocols, while patients receive study-related medication, supplies, and testing at no charge plus per-visit stipends. The customer base is two-sided, with pharmaceutical sponsors and CROs as paying customers and patients with metabolic or chronic conditions plus healthy volunteers as the participant supply. Go-to-market combines community-led patient recruitment (volunteer forms, free health classes, Sugar Talk webinars, and events such as the DREAM Back To School Giveaway) with a dedicated Sponsors & CROs channel for trial referrals. Marketing is anchored on a blog covering diabetes management, diet, exercise, and research updates, supported by Facebook, LinkedIn, and Instagram activity and an email newsletter.

Short descriptiontext

Lucas Research is a privately-held clinical research site network founded in 2004 that specializes in endocrinology and metabolic disease trials for pharmaceutical sponsors, operating three North Carolina sites and recruiting patients via community outreach and free Fibroscan liver screenings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMorehead City, United States
HQ citystring
Morehead City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, endocrinology clinical trials, metabolic disease research, fibroscan liver scanning, pharmaceutical trial site
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Services
TypeProfessional Services
Description

Lucas Research conducts clinical trials on behalf of pharmaceutical companies and sponsors. The company receives compensation from sponsors for conducting studies. Study participants receive study-related medication, supplies, and testing at no charge, and are paid for each visit they attend.

lucasresearch.org
2Patient Care Services
TypeProfessional Services
Description

Provides healthcare services including complimentary appointments with doctors, health screenings, and ongoing patient care. Services are offered at no charge to patients as part of clinical trial participation.

lucasresearch.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lucas Research is a clinical research site network that recruits participants and conducts clinical trials in endocrinology and metabolic disease for pharmaceutical sponsors and CROs. It runs studies on diabetes, fatty liver disease, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders across three North Carolina offices. The site also provides complimentary Fibroscan liver assessments and a patient portal as participant-facing services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Dr. Lucas has conducted over 250 clinical research studies
Product overview1 text field

Lucas Research is a clinical research site network founded by Dr. K. Jean Lucas in 2004, specializing in endocrinology-related clinical trials and metabolic disease research. The company operates as a unified clinical research platform offering three core services: clinical research studies for conditions including fatty liver, cholesterol/triglycerides, celiac disease, diabetes, arthritis, and obesity; Fibroscan liver diagnostic imaging services; and a patient portal for participant management. The company primarily serves the pharmaceutical industry and local communities in North Carolina, recruiting volunteer participants for clinical trials investigating new medications and treatment approaches.

Product and service3 records
1Clinical Research Studies
CategoryClinical Trial Services
Description

Clinical research trials for medical conditions including fatty liver disease, cholesterol/triglycerides, celiac disease, diabetes, arthritis, obesity, and related metabolic disorders. Studies are conducted on behalf of pharmaceutical sponsors and CROs for adult participants meeting protocol criteria.

2Fibroscan Liver Scan
CategoryDiagnostic Imaging Service
Description

Non-invasive liver health assessment using ultrasound-based transient elastography to measure liver stiffness and fat content, offered free to patients and study participants to evaluate liver condition without needles or painful procedures.

3Patient Portal
CategoryPatient Engagement Service
Description

Secure online patient portal that allows research participants to access their health information, manage appointments, and communicate with the Lucas Research care team.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lucas Research serves as a clinical trial site conducting studies on behalf of pharmaceutical companies. These partnerships involve executing clinical protocols for new drug development across metabolic and endocrine conditions.

2Contract Research Organizations (CROs)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnerships with CROs who manage clinical trial operations and delegate site responsibilities to Lucas Research for patient recruitment and study execution.

lucasresearch.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the largest US clinical trial site networks, operating integrated research sites across multiple therapeutic areas. Comparable to Lucas Research as a multi-site clinical research operator serving pharma sponsors, but at significantly greater scale and geographic reach.

TypeDirect peer
Description

Independent clinical research site network operating across the Southeastern US, conducting trials in metabolic, endocrine, and other therapeutic areas. Closely comparable to Lucas Research in size, regional footprint, and metabolic/endocrine specialization.

TypeDirect peer
Description

Multi-therapeutic clinical trial site network operating across the Southeastern US with multiple locations. Highly comparable to Lucas Research in operating model (independent site network serving pharma sponsors), therapeutic breadth, and US regional focus.

TypeBroad incumbent
Description

National clinical research site network leveraging electronic health records and a "Research Ready" model to expand trial access. Directly comparable to Lucas Research as a site network serving pharma sponsors, but operating at national scale with technology-enabled patient identification.

TypeDirect peer
Description

Multi-site clinical research organization operating across the US with strong metabolic, endocrine, and cardiology trial capabilities. Comparable to Lucas Research as a multi-site CRO serving pharma sponsors in therapeutic areas where Lucas specializes.

6National Research Institute
TypeDirect peer
Description

Multi-site clinical research organization with metabolic, endocrine, and GI therapeutic expertise. Comparable to Lucas Research as an independent site network executing trials in the same therapeutic categories.

7Hassman Research Institute
TypeDirect peer
Description

Independent clinical research site in New Jersey conducting endocrinology and metabolic disease trials with a long-tenured principal investigator. Closely comparable to Lucas Research as a PI-led, founder-driven site specializing in metabolic/endocrine trials.

8Drug Studies America
TypeDirect peer
Description

Independent multi-therapeutic clinical research site network. Comparable to Lucas Research as a US-based site network serving pharma sponsors across multiple chronic disease indications.

TypeRegional player
Description

Independent clinical research site on the Gulf Coast operating in similar chronic disease and metabolic indications. Comparable to Lucas Research in site operating model and therapeutic focus, but serving a different regional patient base.

TypeDirect peer
Description

Independent clinical research site in Texas with metabolic, endocrine, and internal medicine trial expertise. Comparable to Lucas Research as a founder/PI-led specialty site network with a community-focused recruitment model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lucas Research

Clinical Research Serviceslucasresearch.org

Lucas Research is a privately-held clinical research site network founded in 2004 that specializes in endocrinology and metabolic disease trials for pharmaceutical sponsors, operating three North Carolina sites and recruiting patients via community outreach and free Fibroscan liver screenings.

What Lucas Research does

Lucas Research is a privately-held clinical research site network founded in 2004 by Dr. K. Jean Lucas, a board-certified endocrinologist with fellowship training at Duke University Medical Center and over 250 completed clinical research studies. The company specializes in endocrine and metabolic disease trials, actively recruiting for studies in non-alcoholic fatty liver disease, diabetes, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders. Operations are anchored by a headquarters in Morehead City, North Carolina, with two additional regional offices in New Bern and Hickory, NC. The firm employs between 11 and 50 staff and is founder-owned with no disclosed institutional investment.

The core technical asset is a Fibroscan device providing non-invasive ultrasound-based transient elastography liver assessments, offered free to patients as both a screening service and a recruitment funnel into trials. A standard Athena-based patient portal supports participant scheduling, communication, and record access. The product portfolio comprises clinical trial execution services (the core offering), Fibroscan diagnostic imaging (a recruitment and community-engagement anchor), and the patient portal. There is no proprietary AI/ML tooling, no API surface, and no mobile application; technology footprint is conventional for a community-based research site.

Lucas Research operates a professional services revenue model: pharmaceutical sponsors and Contract Research Organizations pay the site to execute clinical protocols, while patients receive study-related medication, supplies, and testing at no charge plus per-visit stipends. The customer base is two-sided, with pharmaceutical sponsors and CROs as paying customers and patients with metabolic or chronic conditions plus healthy volunteers as the participant supply. Go-to-market combines community-led patient recruitment (volunteer forms, free health classes, Sugar Talk webinars, and events such as the DREAM Back To School Giveaway) with a dedicated Sponsors & CROs channel for trial referrals. Marketing is anchored on a blog covering diabetes management, diet, exercise, and research updates, supported by Facebook, LinkedIn, and Instagram activity and an email newsletter.

Lucas Research firmographics

Firmographics
Name
Lucas Research
Legal name
Lucas Research
Website
https://lucasresearch.org
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Lucas Research is a privately-held clinical research site network founded in 2004 that specializes in endocrinology and metabolic disease trials for pharmaceutical sponsors, operating three North Carolina sites and recruiting patients via community outreach and free Fibroscan liver screenings.
Ownership category
akta.pro rank

Lucas Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical research services
  • Endocrinology clinical trials
  • Metabolic disease research
  • Fibroscan liver scanning
  • Pharmaceutical trial site

Where Lucas Research is headquartered

Location

Headquarters

HQ city
Morehead City
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Lucas Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: Lucas Research conducts clinical trials on behalf of pharmaceutical companies and sponsors. The company receives compensation from sponsors for conducting studies. Study participants receive study-related medication, supplies, and testing at no charge, and are paid for each visit they attend.
  2. Patient Care Services: Provides healthcare services including complimentary appointments with doctors, health screenings, and ongoing patient care. Services are offered at no charge to patients as part of clinical trial participation.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Lucas Research product offering

Product offering

Core offering

Lucas Research is a clinical research site network that recruits participants and conducts clinical trials in endocrinology and metabolic disease for pharmaceutical sponsors and CROs. It runs studies on diabetes, fatty liver disease, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders across three North Carolina offices. The site also provides complimentary Fibroscan liver assessments and a patient portal as participant-facing services.

Product overview

Lucas Research is a clinical research site network founded by Dr. K. Jean Lucas in 2004, specializing in endocrinology-related clinical trials and metabolic disease research. The company operates as a unified clinical research platform offering three core services: clinical research studies for conditions including fatty liver, cholesterol/triglycerides, celiac disease, diabetes, arthritis, and obesity; Fibroscan liver diagnostic imaging services; and a patient portal for participant management. The company primarily serves the pharmaceutical industry and local communities in North Carolina, recruiting volunteer participants for clinical trials investigating new medications and treatment approaches.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Studies Clinical research trials for medical conditions including fatty liver disease, cholesterol/triglycerides, celiac disease, diabetes, arthritis, obesity, and related metabolic disorders. Studies are conducted on behalf of pharmaceutical sponsors and CROs for adult participants meeting protocol criteria.
  • Fibroscan Liver Scan Non-invasive liver health assessment using ultrasound-based transient elastography to measure liver stiffness and fat content, offered free to patients and study participants to evaluate liver condition without needles or painful procedures.
  • Patient Portal Secure online patient portal that allows research participants to access their health information, manage appointments, and communicate with the Lucas Research care team.

Quantifiable outcome

  • Dr. Lucas has conducted over 250 clinical research studies

Companies that use Lucas Research

Customer profile

Segments4 records

Ideal customer profiles2 records

Lucas Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Lucas Research partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Pharmaceutical SponsorscoreStrategic or Co-development PartnerLucas Research serves as a clinical trial site conducting studies on behalf of pharmaceutical companies. These partnerships involve executing clinical protocols for new drug development across metabolic and endocrine conditions.
  • Contract Research Organizations (CROs)coreStrategic or Co-development PartnerPartnerships with CROs who manage clinical trial operations and delegate site responsibilities to Lucas Research for patient recruitment and study execution.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Lucas Research competitors and assessment

Company assessment

Broad incumbents

  • Velocity Clinical Research: One of the largest US clinical trial site networks, operating integrated research sites across multiple therapeutic areas. Comparable to Lucas Research as a multi-site clinical research operator serving pharma sponsors, but at significantly greater scale and geographic reach.
  • Elligo Health Research: National clinical research site network leveraging electronic health records and a "Research Ready" model to expand trial access. Directly comparable to Lucas Research as a site network serving pharma sponsors, but operating at national scale with technology-enabled patient identification.

Direct peers

  • Meridien Research: Independent clinical research site network operating across the Southeastern US, conducting trials in metabolic, endocrine, and other therapeutic areas. Closely comparable to Lucas Research in size, regional footprint, and metabolic/endocrine specialization.
  • Accel Research Sites: Multi-therapeutic clinical trial site network operating across the Southeastern US with multiple locations. Highly comparable to Lucas Research in operating model (independent site network serving pharma sponsors), therapeutic breadth, and US regional focus.
  • Flourish Research: Multi-site clinical research organization operating across the US with strong metabolic, endocrine, and cardiology trial capabilities. Comparable to Lucas Research as a multi-site CRO serving pharma sponsors in therapeutic areas where Lucas specializes.
  • National Research Institute: Multi-site clinical research organization with metabolic, endocrine, and GI therapeutic expertise. Comparable to Lucas Research as an independent site network executing trials in the same therapeutic categories.
  • Hassman Research Institute: Independent clinical research site in New Jersey conducting endocrinology and metabolic disease trials with a long-tenured principal investigator. Closely comparable to Lucas Research as a PI-led, founder-driven site specializing in metabolic/endocrine trials.
  • Drug Studies America: Independent multi-therapeutic clinical research site network. Comparable to Lucas Research as a US-based site network serving pharma sponsors across multiple chronic disease indications.
  • Research Institute of Dallas: Independent clinical research site in Texas with metabolic, endocrine, and internal medicine trial expertise. Comparable to Lucas Research as a founder/PI-led specialty site network with a community-focused recruitment model.

Regional players

  • Innovative Research of West Florida: Independent clinical research site on the Gulf Coast operating in similar chronic disease and metabolic indications. Comparable to Lucas Research in site operating model and therapeutic focus, but serving a different regional patient base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Lucas Research social profiles

Digital presence

Lucas Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lucas Research leadership team

Management profile

Number of profiles

Profiles2 records

Lucas Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lucas Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lucas Research

What does Lucas Research do?

Lucas Research is a clinical research site network that recruits participants and conducts clinical trials in endocrinology and metabolic disease for pharmaceutical sponsors and CROs. It runs studies on diabetes, fatty liver disease, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders across three North Carolina offices. The site also provides complimentary Fibroscan liver assessments and a patient portal as participant-facing services.

Is Lucas Research a public or private company?

Lucas Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lucas Research founded?

Lucas Research was founded in 2004. It employs 11 to 50 people.

Where is Lucas Research based?

Lucas Research is headquartered in Morehead City, United States, in the North America region.

How does Lucas Research make money?

Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are patient Care Services.

Who are Lucas Research's main competitors?

Broad incumbents on record are Velocity Clinical Research and Elligo Health Research. Direct peers are Meridien Research, Accel Research Sites, Flourish Research, National Research Institute, Hassman Research Institute, Drug Studies America and Research Institute of Dallas. Innovative Research of West Florida is listed as a regional player.

Does Lucas Research have an API?

No public API is recorded for Lucas Research.

What industry is Lucas Research in?

Lucas Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals